Welcome to our dedicated page for 111 SEC filings (Ticker: YI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
111, Inc. filings document foreign-issuer current reports furnished on Form 6-K, primarily covering unaudited quarterly and annual financial results for its China healthcare platform. The disclosures report net revenues, gross segment profit, operating expenses, operating cash flow and segment activity tied to the company’s B2B and B2C healthcare businesses.
The filing record also describes the company’s transition toward an asset-light warehouse partnership model, including subsidiary divestitures that shifted certain fulfillment facilities into partner roles. These reports provide formal disclosure of business performance, margin trends, liquidity measures, ADR reporting status and material operating updates furnished to U.S. markets.
111, Inc. director Sun Jian David reported a series of RSU-related transactions in Class A ordinary shares. He received grants of 378,737 RSUs on May 11, 2026 that vested in full on the grant date and 413,168 RSUs on May 12, 2026 that vest in four annual installments. On May 26, 2026 and May 27, 2026, a total of 99,720 Class A shares were sold solely to satisfy tax withholding obligations tied to RSU vesting, at prices of $0.27 and $0.25 per share. After these transactions, Sun directly holds 710,551 Class A shares.
111, Inc. director Chen Yang Luke reported RSU awards and related tax-share sales. He received grants of 54,759 and 413,168 RSUs (Class A), each representing one Class A ordinary share. As RSUs vested, he sold 1,440 and 3,400 Class A shares to satisfy tax withholding obligations, and held 589,382 Class A shares directly after the latest transaction.
Teo Nee Chuan reported acquisition or exercise transactions in this Form 4 filing.
111, Inc. director Teo Nee Chuan reported equity compensation in the form of restricted stock units (RSUs) tied to Class A ordinary shares. The filing shows grants of 378,737 RSUs that vest in full on May 11, 2026 and 413,168 RSUs granted on May 12, 2026, scheduled to vest in four equal annual installments from that date. Following the latest grant, Teo directly holds 811,889 RSUs representing the right to receive an equal number of Class A shares.
Chen Yang Luke reported acquisition or exercise transactions in this Form 4 filing.
111, Inc. director Chen Yang Luke reported multiple grants of restricted stock units (RSUs) tied to the company’s Class A ordinary shares. On May 12, 2026, he received 413,168 RSUs (Class A), each representing one Class A ordinary share. This award vests in four equal annual installments on the first through fourth anniversaries of May 12, 2026, with pro rata vesting in a year if his service ends other than for cause.
The filing also shows a separate grant of 54,759 RSUs (Class A) dated May 11, 2026, which fully vested on the grant date, and an earlier grant of 126,295 RSUs dated September 8, 2023. Following the most recent grant, Luke directly holds 594,222 Class A RSUs or shares, reflecting his equity-based compensation rather than open-market purchases or sales.
Luo Jun Justin reported acquisition or exercise transactions in this Form 4 filing.
111, Inc. director Luo Jun Justin reported awards of restricted stock units (RSUs) tied to the company’s Class A ordinary shares. On May 11, 2026, he received 378,737 RSUs that vest in full on the grant date. On May 12, 2026, he received a further 413,168 RSUs that vest 25% on each of the first four anniversaries of May 12, 2026, with pro rata vesting in a year if his service ends other than for cause. Earlier, on September 12, 2018, he was granted 18,366 RSUs. Following the most recent grant, his direct holdings reported in this filing include 810,271 RSUs.
Sun Jian David reported acquisition or exercise transactions in this Form 4 filing.
111, Inc. director Sun Jian David reported awards of restricted stock units (RSUs) tied to the company’s Class A ordinary shares. On May 11, 2026, he received 378,737 RSUs that vest in full on the grant date, giving an immediate right to the same number of Class A shares.
On May 12, 2026, he was granted a further 413,168 RSUs, scheduled to vest in four equal 25% installments on each anniversary of May 12, 2026, with pro rata vesting in certain termination scenarios. Earlier, on September 12, 2018, he had received 18,366 RSUs. Following the latest grant, his directly held RSUs total 810,271, reflecting compensation awards rather than open‑market share purchases or sales.
111, Inc., a Cayman Islands holding company for PRC healthcare and pharmacy operations, files its annual report describing a complex China-focused structure and risk profile. Investors in its ADSs hold equity in the offshore parent, not directly in Chinese operating subsidiaries.
The report highlights extensive PRC regulatory, data security and foreign exchange constraints that could limit moving cash out of China and Hong Kong, and notes that no dividends were received from PRC subsidiaries or paid to shareholders for 2023–2025. The company remains loss-making, with net losses in each of those three years, and warns that changing Chinese oversight of offshore listings, cybersecurity and HFCAA-related audit access could jeopardize its U.S. trading status.
111, Inc. also discloses a sizable redemption obligation tied to a planned but uncompleted STAR Market listing of a major PRC subsidiary, with about RMB1.1 billion recorded as redeemable interests and related liabilities and several hundred million RMB already repaid or scheduled under restructuring agreements, which could pressure liquidity if further redemptions occur.
111, Inc. reported fourth quarter and full-year 2025 results showing lower revenue but improved profitability metrics as it shifts to an asset-light warehouse partnership model.
Net revenues were RMB12.6 billion for 2025, down 12.8% from 2024, while operating costs fell by the same percentage. GAAP loss from operations was RMB2.4 million, compared with RMB2.1 million of operating income in 2024, but non-GAAP income from operations remained positive at RMB7.7 million.
For Q4 2025, net revenues declined 26.7% year over year to RMB2.8 billion, yet loss from operations narrowed sharply to RMB0.3 million and non-GAAP income from operations reached RMB0.2 million. The company generated positive operating cash flow of RMB119.1 million for 2025 and ended the year with RMB611.3 million in cash, restricted cash and short-term investments.
111, Inc. director Teo Nee Chuan filed an initial ownership report showing holdings of 19,984 RSUs tied to Class A ordinary shares. Each RSU represents a contingent right to receive one Class A share, and all of these RSUs were fully vested as of the Form 3 date.
111, Inc. director Luo Jun Justin filed an initial ownership report showing holdings of 18,366 RSUs tied to Class A ordinary shares. Each RSU represents a contingent right to receive one Class A ordinary share, and the filing notes that all such RSUs have fully vested as of the date of the Form 3. This filing records existing ownership and does not reflect any new buy or sell transaction.